Unlock instant, AI-driven research and patent intelligence for your innovation.

Compound with anti-tumor activity and its preparing method

A compound and extract technology, applied in the field of novel triterpenoids and their preparation, can solve the problem of no anti-tumor activity and the like

Inactive Publication Date: 2007-01-24
FUDAN UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, little is known about its chemical composition at home and abroad, let alone its anti-tumor activity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound with anti-tumor activity and its preparing method
  • Compound with anti-tumor activity and its preparing method
  • Compound with anti-tumor activity and its preparing method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] Example 1 Extraction of 7β, 24β, 25-trihydroxy-9,19-cycloartin-1-en-3-one 25-O-β-D-glucopyranoside

[0053] A. After crushing 1kg of bitter horse bean, put it into the extraction tank

[0054] B. 8 L of 95% ethanol was refluxed and extracted 3 times, each time for 2 hours, and the ethanol was recovered to obtain 103 g of ethanol extract.

[0055] C. Dissolve the ethanol extract in 1L of water, and extract 3 times with an equal volume of chloroform to obtain 33.7 g of chloroform extract.

[0056] D. The chloroform extract was subjected to silica gel column chromatography (wet packing, dry loading), the ratio of the sample volume to the total amount of silica gel was 1:5, and after elution with chloroform:methanol (100:2) for 3 retention volumes, Recrystallization gave 7β, 24β, 25-trihydroxy-9,19-cycloartin-1-en-3-one 25-O-β-D-glucopyranoside (147 mg).

Embodiment 2

[0057] Example 2 Extraction of 7β, 24β, 25-trihydroxy-9, 19-cycloartin-1-en-3-one 25-O-β-D-glucopyranoside

[0058] a After crushing 1kg of bitter horse bean, put it into the extraction tank

[0059] b Soak and extract in 10L methanol for 3 times, each time for 12 hours, recover methanol, and obtain 116g of methanol extract.

[0060] c Dissolve the methanol extract in 800 mL of water, and extract twice with an equal volume of dichloromethane to obtain 31.9 g of dichloromethane extract.

[0061] d The dichloromethane extract was subjected to alumina column chromatography (wet column loading, dry loading), the sample volume to alumina weight ratio was 1:10, and 4 samples were eluted with dichloromethane:methanol (100:3). After volume retention, recrystallization gave 7β,24β,25-trihydroxy-9,19-cycloaltin-1-en-3-one 25-O-β-D-glucopyranoside (132 mg).

Embodiment 3

[0062] Example 3 Anti-tumor effect of 7β, 24β, 25-trihydroxy-9, 19-cycloartin-1-en-3-one 25-O-β-D-glucopyranoside in vitro

[0063] Take the cells in the logarithmic phase 3×10 per well 4 Inoculated on a 96-well plate, discarded the supernatant after 12 hours, and administered according to the following groups: Tumor cells were divided into groups without treatment and groups with treatment (concentration 0-100 μM), each group had 6 replicate wells, cultured for 24 hours, discarded Add 50 μl of culture medium with MTT (tetrazolium salt, Sigma product) to the supernatant and incubate for 4 hours (0.5 mg / mL), add 100 μl DMSO (dimethyl sulfoxide), shake for 1 hour, and measure at 570 nm on a microplate reader OD value. The normal cell line L02 was used as a control. Repeat 3 times.

[0064] The results showed that as the drug concentration increased, the cell proliferation activity decreased respectively compared with the corresponding control group without drug addition, indi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to biochemical technology, and is especially one kind of compound with antitumor activity and its preparation process. The compound with antitumor activity is prepared with Mongolia medicine material Sphaerophysa salsula (Pall.) dc as raw material by separation and purification. The compound is used in preparing antitumor medicine preparation for treating liver cancer, cerebroma, lung cancer, mammary cancer, prostatic carcinoma, etc.

Description

technical field [0001] The invention belongs to the field of biochemical medicine, and relates to a compound with antitumor activity and a preparation method thereof. Specifically, the invention relates to a compound with antitumor activity extracted from Mongolian medicine Sphaerophysa salsula (Pall.) DC. A novel triterpenoid compound with obvious tumor prevention and treatment effects and a preparation method thereof. Background technique [0002] At present, more than 6 million people die of cancer every year in the world, and 8 million new cases are diagnosed, and this number is still increasing year by year. Among the 1.3 billion people in my country, there are millions of new cancer patients every year, about 2 million patients waiting for treatment, and about 1.3 million deaths. It is estimated that by 2006, 1.7 million people will die of cancer in our country, and cancer has become a major killer of human beings! However, although the traditional treatment mode bas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07J53/00C07J75/00A61K31/704A61P35/00
Inventor 朱焕章马忠俊
Owner FUDAN UNIV